Trial Profile
A Phase I Study of TS-1, Cisplatin & RAD001 (Everolimus).
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 21 Feb 2014
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Cisplatin; Gimeracil/oteracil/tegafur
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 21 Feb 2014 Status changed from not yet recruiting to discontinued.
- 05 Apr 2010 New trial record